Trial Outcomes & Findings for Chlorhexidine Drying Time (NCT NCT02095535)
NCT ID: NCT02095535
Last Updated: 2017-08-07
Results Overview
Length of drying time from when Chloraprep solution is applied to skin to when skin is deemed dry.
Recruitment status
COMPLETED
Target enrollment
20 participants
Primary outcome timeframe
At Chloraprep application
Results posted on
2017-08-07
Participant Flow
Participant milestones
| Measure |
Study Group
All study participants
Chlorhexidine gluconate: antiseptic
|
|---|---|
|
Recruitment
STARTED
|
20
|
|
Recruitment
COMPLETED
|
18
|
|
Recruitment
NOT COMPLETED
|
2
|
|
Analysis
STARTED
|
18
|
|
Analysis
COMPLETED
|
18
|
|
Analysis
NOT COMPLETED
|
0
|
Reasons for withdrawal
| Measure |
Study Group
All study participants
Chlorhexidine gluconate: antiseptic
|
|---|---|
|
Recruitment
Protocol Violation
|
2
|
Baseline Characteristics
Race and Ethnicity were not collected from any participant.
Baseline characteristics by cohort
| Measure |
Study Group
n=18 Participants
All study participants
Chlorhexidine gluconate: antiseptic
|
|---|---|
|
Age, Categorical
<=18 years
|
0 Participants
n=18 Participants
|
|
Age, Categorical
Between 18 and 65 years
|
18 Participants
n=18 Participants
|
|
Age, Categorical
>=65 years
|
0 Participants
n=18 Participants
|
|
Sex: Female, Male
Female
|
18 Participants
n=18 Participants
|
|
Sex: Female, Male
Male
|
0 Participants
n=18 Participants
|
|
Region of Enrollment
Canada
|
18 participants
n=18 Participants
|
PRIMARY outcome
Timeframe: At Chloraprep applicationLength of drying time from when Chloraprep solution is applied to skin to when skin is deemed dry.
Outcome measures
| Measure |
Study Group
n=18 Participants
All study participants
Chlorhexidine gluconate: antiseptic
|
|---|---|
|
Length of Drying Time
|
123 seconds
Standard Deviation 32
|
Adverse Events
Study Group
Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths
Serious adverse events
Adverse event data not reported
Other adverse events
Adverse event data not reported
Additional Information
Tashya De Silva
UBC Department of Anesthesia - BC Women's Hospital
Phone: 604-875-2158
Email: [email protected]
Results disclosure agreements
- Principal investigator is a sponsor employee
- Publication restrictions are in place